These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35705237)

  • 21. Changes of immunosuppressive medication because of COVID-19 by patients with chronic inflammatory rheumatic diseases: anxiety was not a major driver.
    Andreica I; Jast R; Rezniczek GA; Kiefer D; Buehring B; Kiltz U; Baraliakos X; Braun J
    Clin Exp Rheumatol; 2022 Nov; 40(11):2044-2051. PubMed ID: 35084321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated to COVID-19 vaccine acceptance in Mexican patients with rheumatic diseases: A cross-sectional and multicenter study.
    Guaracha-Basañez GA; Contreras-Yáñez I; Álvarez-Hernández E; Reyes-Cordero G; Flores-Alvarado DE; González-Chávez SA; Galarza-Delgado DÁ; Martínez-Leyva PR; Moctezuma-Ríos JF; García-García C; Medrano-Ramírez G; Gastelum-Strozzi A; Pacheco-Tena C; Peláez-Ballestas I; Pascual-Ramos V
    Hum Vaccin Immunother; 2022 Nov; 18(5):2049131. PubMed ID: 35389817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study.
    Svensson ALL; Emborg HD; Bartels LE; Ellingsen T; Adelsten T; Cordtz R; Dreyer L; Obel N
    Ann Rheum Dis; 2023 Oct; 82(10):1359-1367. PubMed ID: 37414519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early experience of COVID-19 vaccine-related adverse events among adolescents and young adults with rheumatic diseases: A single-center study.
    Haslak F; Gunalp A; Cebi MN; Yildiz M; Adrovic A; Sahin S; Barut K; Kasapcopur O
    Int J Rheum Dis; 2022 Mar; 25(3):353-363. PubMed ID: 34978376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To Vaccinate or not to Vaccinate; That is the Question! (New Insights into COVID-19 Vaccination).
    El-Nakeep S
    Curr Mol Med; 2022; 22(7):567-571. PubMed ID: 33982651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Social Attitude to COVID-19 and Influenza Vaccinations after the Influenza Vaccination Season and between the Second and Third COVID-19 Wave in Poland, Lithuania, and Ukraine.
    Zaprutko T; Kremin Y; Michalak M; Bernatoniene J; Zaprutko L; Hudz N; Stolecka A; Cynar J; Niewczas K; Sprawka J; Skorupska P; Wróbel J; Ratajczak P; Kopciuch D; Paczkowska A; Kus K; Hromovyk B
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination.
    Kreps S; Prasad S; Brownstein JS; Hswen Y; Garibaldi BT; Zhang B; Kriner DL
    JAMA Netw Open; 2020 Oct; 3(10):e2025594. PubMed ID: 33079199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination coverage among COVID-19 prevention and control management teams at primary healthcare facilities in China and their attitudes towards COVID-19 vaccine: a cross-sectional online survey.
    Yan YY; Wang HT; Fan TY; Sun XJ; Du ZH; Sun XM
    BMJ Open; 2022 Apr; 12(4):e056345. PubMed ID: 35393315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disease relapse rate in children with autoimmune rheumatic diseases after COVID-19 infection and vaccination.
    Šinkovec Savšek T; Zajc Avramovič M; Avčin T; Korva M; Avšič Županc T; Toplak N
    Pediatr Rheumatol Online J; 2023 May; 21(1):46. PubMed ID: 37208721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fears about COVID-19 and perceived risk among people with rheumatoid arthritis or ankylosing spondylitis following the initial lockdown in Aotearoa New Zealand.
    Treharne GJ; Johnstone G; Fletcher BD; Lamar RSM; White D; Stebbings S; Harrison A
    Musculoskeletal Care; 2022 Jun; 20(2):290-298. PubMed ID: 34388290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study.
    Andreica I; Roman I; Redeker I; Baraliakos X; Braun J; Kiltz U
    RMD Open; 2023 Jun; 9(2):. PubMed ID: 37295840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine.
    Moutsopoulos HM
    J Autoimmun; 2021 Jul; 121():102649. PubMed ID: 33984571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
    Raptis CE; Berger CT; Ciurea A; Andrey DO; Polysopoulos C; Lescuyer P; Maletic T; Riek M; Scherer A; von Loga I; Safford J; Lauper K; Möller B; Vuilleumier N; Finckh A; Rubbert-Roth A
    Front Immunol; 2022; 13():1016927. PubMed ID: 36311791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parents' intent to vaccinate against influenza during the COVID-19 pandemic in two regions in Switzerland.
    Seiler M; Goldman RD; Staubli G; Hoeffe J; Gualco G; Manzano S; Part Of The International Covid-Parental Attitude Study Covipas Group
    Swiss Med Wkly; 2021 May; 151():w20508. PubMed ID: 34002802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 Vaccination Perceptions in Patients With Rheumatic Disease: A Cross-Sectional Online Survey.
    Butt IN; van Eeden C; Burns KK; Saxinger L; Clifford A; Tervaert JWC; Yacyshyn EA
    J Rheumatol; 2023 May; 50(5):690-696. PubMed ID: 36521919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases.
    Papagoras C; Fragoulis GE; Zioga N; Simopoulou T; Deftereou K; Kalavri E; Zampeli E; Gerolymatou N; Kataxaki E; Melissaropoulos K; Panopoulos S; Fragiadaki K; Evangelatos G; Bournia VK; Arida A; Karamanakos A; Pappa M; Panagiotopoulos A; Koutsianas C; Mparouta G; Dimitroulas T; Liossis SN; Tektonidou MG; Kravvariti E; Kougkas N; Georgiou P; Voulgari P; Elezoglou A; Bogdanos DP; Vassilopoulos D; Sfikakis PP
    Ann Rheum Dis; 2022 Jul; 81(7):1013-1016. PubMed ID: 34758975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in attitudes to vaccination as a result of the COVID-19 pandemic: A longitudinal study of older adults in the UK.
    Gallant AJ; Nicholls LAB; Rasmussen S; Cogan N; Young D; Williams L
    PLoS One; 2021; 16(12):e0261844. PubMed ID: 34941951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 Vaccines and Public Anxiety: Antibody Tests May Be Widely Accepted.
    Liu L; Wang X; Li X; Li N
    Front Public Health; 2022; 10():819062. PubMed ID: 35602124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis.
    Burian K; Heidler F; Frahm N; Hecker M; Langhorst SE; Mashhadiakbar P; Streckenbach B; Baldt J; Meißner J; Richter J; Zettl UK
    Sci Rep; 2024 May; 14(1):12248. PubMed ID: 38806524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.